- Global Pharma News & Resources

Coronary Stent Market exhibiting CAGR of 3.2% from 2023 to 2032, owing to growing geriatric population at higher risk of these cardiac diseases | insightSLICE

The global Coronary Stent market size was estimated to be US$ 9 billion in 2021 and is expected grow at a CAGR of 3.2% between 2023 to 2032.

Coronary stents (CS) are metallic, expandable devices which are placed inside stenotic coronary arteries as a result of underlying atherosclerosis. Stents are utilized to compress the atherosclerotic plaques that have built up on the coronary arterial walls and remove them.

They are frequently utilized in treatments for deep vein thrombosis, peripheral artery disease, coronary heart disease, and others.

Access the sample report:

Today, the risk of cardiovascular diseases is rising as a result of unhealthy life choices. Medications, balloon angioplasty, stenting, and coronary artery bypass surgery are just a few of the treatments utilized to treat coronary heart disease.

The coronary stent is one such surgical method that is widely used to treat coronary heart disease-related complications. During the projection period, it is expected that the market for coronary stents would grow at a CAGR of close to 7.0%.

The market value will also increase as a result of cutting-edge advances in drug-eluting stents including bifurcation stents and biodegradable materials.

The key players of the Global Coronary Stent Market are:

Braun Medical Inc., Biosensors International Group, Abbott Laboratories, Ltd., Terumo Corporation, Biotronik SE & Co. KG, Medtronic PLC, Cook Medical Technologies, and Translumina GmbH are significant market leaders in the global coronary stent industry.

To stay competitive in the market, major competitors in the coronary stent market are putting a lot of effort into creating cutting-edge techniques for precise stent implantation.

The report for the Coronary Stent Market takes the competitive setting into account and will include a summary and market outlook for top players worldwide.

Additionally, the report would include information on significant advancements, global and regional sales networks, business models, stability and open market review, R&D activities, manufacturing facilities, brand portfolio, management, and executive teams for all the players in this market.

For instance, according to the business and regional analysis of the firm, Medtronic PLC, which generated revenues of approximately USD 30,557 Million in 2019, the Cardiac & Vascular Group business section is the firm’s dominant segment, accounting for 53% of the company’s overall revenue.

Read more about the report inclusions:

What is covered in our coronary stent market report?

This report offers an in-depth assessment of significant market participants with a focus on every operational company and will identify the coronary stent-producing divisions of major companies.

Additionally, the company’s market share in the global coronary stent market will be determined based on available resources.

One such example from our report will be Medtronic PLC They have four main divisions called Cardiac and Vascular Group, Minimally Invasive Therapies, Restorative Therapies, and Diabetes Group. Coronary Stent is manufactured and sold by the Cardiac and Vascular Group, which contributed US$11,505,000,000 in revenue in 2019.

The study also takes into account critical competitive data from all the coronary stent manufacturers, such as corporate strategy, market position, key developments, SWOT analysis, and development and research priorities.

The actors involved in the market’s distribution chain and cost structure, as well as their contributions, will be taken into account in the analysis of the global market for coronary stents. All of the items in the firm’s Coronary Stent market business area would be the main emphasis of the product offering.

Similar to this, the current developments segment would concentrate on the most recent corporate activities, including growth strategies, new product launches, mergers and acquisitions, and strategic partnerships and collaborations in the worldwide coronary stent market.

Related reports:

Global Artificial Organs Market:

Global Adaptive Optics Market:

Global Coronary Stent Market Key Segments:

By Product

  • Bare Metal Stents (BMS)
  • Drug-Eluting Stents (DES)
    • Biodegradable
    • Non-Biodegradable
  • Bioresorbable Vascular Scaffold (BVS)

By Material

  • Metal
  • Composite
  • Bio-absorbable material

By End Use

  • Hospital
  • Ambulatory surgical center
  • Others

By Geography:

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Rest of South America

Factors affecting regional growth:

Due to the high prevalence of patients with cardiovascular disorders and the accessibility of healthcare facilities in the region, North America held the greatest share of the global market for coronary stents.

The market for coronary stents in Europe is likely to expand steadily over the course of the forecast period, with Western European nations expected to contribute the most.

Proceed to purchase:

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at

Contact us:

Alex R

+1 707 736 6633

Linkedin | Twitter

Editor Details

Last Updated: 28-Nov-2022